Recently, Shanghai intends to set up a total size of 89 billion yuan of three industrial pioneer mother fund. And this is the latest big contribution from a major domestic city following Beijing’s release of a new batch of industrial investment funds with a total size of 50 billion yuan. Among them, 21.5 billion yuan will be invested in the field of biomedicine – innovative drugs and high-end preparations, high-end medical devices, biotechnology, high-end pharmaceutical equipment and other fields. more…
According to MDCLOUD’s public bidding data, the surgical power system market in China showed a more concentrated trend in the first quarter of 2024. The top four brands in terms of sales accounted for nearly 70% of the total, an increase of about 13 percentage points compared to 57% in the same period last year. Among them, Xishan and Medtronic were particularly prominent, with a combined market share of over 63%. more…
On 1 July 2024, the revised Code of Practice for the Quality Management of Medical Device Businesses (“the Code”) by the NMPA has came into force. The former State Food and Drug Administration’s Announcement on the Enforcement of the Code of Practice for the Quality Management of Medical Device Operations (No. 58 of 2014) is repealed at the same time.
What are the changes in the new Code? What do medical device operators need to pay attention to? For your better understanding, some of the key contents are extracted below: more…
In recent years, China has focused on supporting the development of high-end and innovative standards for artificial intelligence medical devices, new biomedical materials, and other fields, striving to fill the gap in innovation standards. As of now, there are 1978 medical device standards, including 272 national standards and 1706 industry standards; There are 269 mandatory standards and 1709 recommended standards, which basically cover various professional technical fields of medical devices. Standardization organizations have been established for medical robots, artificial intelligence medical devices, medical equipment industry and applications, traditional Chinese medicine devices, and more. There are now 39 medical device standardization organizations. more…
Online Settlement, Cracking the Payback Problem
Recently, the Healthcare Security Bureau of Hefei City, Anhui Province, disbursed the first national centralized quantity procurement drug payment of 3.08 million yuan to Anhui Tianxing Pharmaceutical Group Co., Ltd. and Huarun Anhui Pharmaceutical Co., Ltd., marking the official implementation of the centralized quantity procurement drug payment model in Hefei City, which is settled directly by the Healthcare Security fund and pharmaceutical enterprises. more…
Facing the challenge of declining foreign investment, China makes another move to stabilise foreign investment more…
Recently, the National Heathcare Security Bureau released a healthcare security update titled Breakthrough! Deepening the Pilot Expansion of Medical Service Price Reform is imminent, which clearly stated that provincial pilot projects will be directly carried out in three provinces including Inner Mongolia, Zhejiang, and Sichuan, and will continue to guide five pilot cities. It is expected that by around 2025, the reform experience will be promoted nationwide. more…
On June 24th, the official website of the Healthcare Security Bureau of Inner Mongolia Autonomous Region issued a Notice on Doing A Good Job in the Centralized Procurement of Drugs and Medical Consumables in 2024, announcing the key work and tasks in the centralized procurement of drugs and medical consumables throughout the region in 2024. more…
